Basic information Safety Supplier Related

antarelix

Basic information Safety Supplier Related

antarelix Basic information

Product Name:
antarelix
Synonyms:
  • antarelix
  • D-Alaninamide, N-acetyl-3-(2-naphthalenyl)-D-alanyl-4-chloro-D-phenylalanyl-3-(3-pyridinyl)-D-alanyl-L-seryl-L-tyrosyl-N6-(aminocarbonyl)-D-lysyl-L-leucyl-N6-(1-methylethyl)-L-lysyl-L-prolyl-
CAS:
151272-78-5
MF:
C74H100ClN15O14
MW:
1459.13
Mol File:
151272-78-5.mol
More
Less

antarelix Chemical Properties

Water Solubility 
>10g/L(temperature not stated)
More
Less

antarelix Usage And Synthesis

Uses

Teverelix (EP 24332) is a GnRH antagonist. Teverelix binds competitively and reversibly to GnRH receptors, thereby suppressing the release of LH and FSH. Teverelix can be used in the research of prostatic hyperplasia, endometriosis, and prostate cancer[1][2].

in vivo

Teverelix (3-300 μg/kg, intramuscular injection) inhibits testosterone in rats[3].
Teverelix (1 mg/kg, s.c, daily for 3 days) abolishes luteal function in stumptailed macaques[4].

Animal Model:Rats[3]
Dosage:300, 100, 30, 10 and 3 μg/kg
Administration:Intramuscular injection
Result:Showed dose-response and time-course of testosterone inhibitory activity.

References

[1] MacLean CM, et al. Pharmacokinetic, Safety, and Pharmacodynamic Properties of Teverelix Trifluoroacetate, a Novel Gonadotropin-Releasing Hormone Antagonist, in Healthy Adult Subjects. Clin Pharmacol Drug Dev. 2022 Feb;11(2):257-269. DOI:10.1002/cpdd.1008
[2] Sperduti S, et al. GnRH Antagonists Produce Differential Modulation of the Signaling Pathways Mediated by GnRH Receptors. Int J Mol Sci. 2019 Nov 7;20(22):5548. DOI:10.3390/ijms20225548
[3] Deghenghi R, et al. Antarelix (EP 24332) a novel water soluble LHRH antagonist. Biomed Pharmacother. 1993;47(2-3):107-10. DOI:10.1016/0753-3322(93)90299-z
[4] Fraser HM, et al. Initiation of high dose gonadotrophin-releasing hormone antagonist treatment during the late follicular phase in the macaque abolishes luteal function irrespective of effects upon the luteinizing hormone surge. Hum Reprod. 1997 Mar;12(3):430-5. DOI:10.1093/humrep/12.3.430

antarelixSupplier

Hangzhou Peptidego Biotech Co.,Ltd.
Tel
0571-87213919
Email
Eric@peptidego.com
Hangzhou Sinoda Pharmaceutical Technology Co. LTD
Tel
0571-87213919 17306812703
Email
3007955328@qq.com
TargetMol Chemicals Inc.
Tel
15002134094
Email
marketing@targetmol.cn
YantaiBio
Tel
13758194781 15083780366
Email
wudegui@tanzhenbio.com
Fuan Bio
Tel
18178976185
Email
3855357086@qq.com
More
Less

antarelix(151272-78-5)Related Product Information